Results 161 to 170 of about 2,663,645 (303)
Association of nephrolithiasis history with adverse outcomes in cardiovascular-kidney-metabolic syndrome. [PDF]
Bi X +9 more
europepmc +1 more source
ABSTRACT While epidemiological studies link fine particulate matter (PM2.5) exposure to metabolic dysfunction‐associated steatotic liver disease (MASLD) and renal dysfunction, a translational gap exists, as most animal models utilize acute, high‐dose exposures that poorly reflect chronic, moderate‐level human scenarios.
Yi‐Siao Chen +11 more
wiley +1 more source
Translational Lifestyle Medicine Approaches to Cardiovascular-Kidney-Metabolic Syndrome. [PDF]
Papadakis Z.
europepmc +1 more source
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) and obstructive sleep apnea (OSA) are comorbid conditions that synergistically increase cardiovascular risk through systemic inflammation and insulin resistance. While continuous positive airway pressure (CPAP) is the standard treatment for OSA, its efficacy in improving hepatic ...
Hsiao‐Chin Shen +10 more
wiley +1 more source
Genomic Structural Equation Modeling Reveals Cardiovascular-Kidney-Metabolic Syndrome Genetic Architecture. [PDF]
Lu C, Li L, Chen J, Chang R, Dong H.
europepmc +1 more source
ABSTRACT Background: Post‐transplant diabetes mellitus (PTDM) is a common complication following liver transplant (LT) and is associated with adverse outcomes. The triacylglycerol‐glucose product (TyG) and the triacylglycerol‐to‐high‐density lipoprotein (HDL) cholesterol ratio (TAG/HDL‐c) are indices that can serve as triacylglycerol‐based proxies for ...
Mateo Chvatal‐Medina +9 more
wiley +1 more source
Editorial: Novel strategies for the clinical management of cardiovascular-kidney-metabolic syndrome. [PDF]
Shen Y, Han J, Ding X.
europepmc +1 more source
White adipose tissue undergoes browning under endogenous and exogenous stimuli, primarily regulated by core molecules such as PRDM16 and UCP1. It exhibits a double‐edged sword effect in metabolic diseases and tumors: while mitigating metabolic disease impacts and suppressing early‐stage tumors through nutritional competition, it may accelerate cachexia
Yingjiao Wang +12 more
wiley +1 more source
The Diminished Cardiorespiratory Fitness in Cardiovascular-Kidney-Metabolic Syndrome
Yuting Liu,1 Yanting Liang,1 Huan Ma,2 Hengyuan Gao,3,4 Xinzhou Zhang1,5 1Department of Nephrology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and ...
Liu Y, Liang Y, Ma H, Gao H, Zhang X
doaj
Development and validation of a prediction model for cardiovascular-kidney-metabolic syndrome progression: a multicenter study. [PDF]
Tu J +5 more
europepmc +1 more source

